Konsume
Interval Day Week Month
Newswire Search Past 90 Days 5 stories 1 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
therapeutics4-
Prominent Journalists
Byline Articles Written Avg Reach
TajSabreen Ahamed 2 -
Prabha Kurup 1 -
RTTNews Staff Writer 1 -
Gayathry Prakash 1 -


Outlook Therapeutics Highlights LYTENAVA FDA Approval And U.S. Commercial Opportunity

RTTNews Staff Writerrttnews.com


Outlook Therapeutics Prices $55 Mln Offering To Support LYTENAVA Launch; Stock Down

Gayathry Prakashrttnews.com


Outlook's LYTENAVA Crosses The FDA Finish Line On Its Fourth Attempt

Prabha Kuruprttnews.com


Outlook Therapeutics Wins FDA Nod For LYTENAVA After Three Setbacks

TajSabreen Ahamedrttnews.com


Outlook Therapeutics' BLA Resubmission For ONS-5010 Accepted By FDA For Wet AMD Review

TajSabreen Ahamedrttnews.com

Execution: 1.34 Seconds. 61.11 mb used.